In a significant step towards advancing early cancer detection in India, Strand Life Sciences, a subsidiary of Reliance ...
Patented platform uses cell-free DNA analysis and machine learning to detect cancer early and identify tissue of origin from ...
A machine learning program that identified patients overdue for colorectal cancer screening helped increase screening rates ...
Caris Life Sciences ® (NASDAQ: CAI), a leading patient-centric, next-generation AI TechBio company and precision medicine ...
The next breakthrough in cancer screening is emerging from the convergence of artificial intelligence and canine biology. That’s the thesis behind SpotitEarly, a startup that recently launched in the ...
7hon MSN
Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection
The patented platform combines genome sequencing, methylation analysis and machine learning to detect cancer and identify its ...
Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection technology ...
Opinion
Worcester Telegram on MSNOpinion
Opinion/Guest column: New tech now closes in faster on cancer
We're on the cusp of a new era in cancer care – one that could dramatically improve survival and quality of life.
5dOpinion
New pathways to early cancer detection could save lives across state | Dr. Emily M. Herzberg
For patients here in the commonwealth and across the country, we’re on the cusp of a new era in cancer care — one that could ...
Reliance’s Strand Life Sciences patents a blood-based technology for early cancer detection, enhancing accuracy and accessibility.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results